Clinical Trial: A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Alzheimer's Disease
Study Type: INTERVENTIONAL
Official Title: Assessment of Safety, Tolerability, and Efficacy Measured by Amyloid Reduction of LY3372993 in Early Symptomatic Alzheimer's Disease
Brief Summary:
The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic Alzheimer's disease (AD).
Read more